The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
October 14, 2020

"Potential Safety Concern" Halts Clinical Trial of Eli Lilly Antibody Treatment
-------------------------------------------------------------------------------

Pharmaceutical giant Eli Lilly has suspended clinical trials of its
monoclonal antibody drug over an unspecified "potential safety concern."
President Trump touted a similar drug produced by Regeneron as a "cure"
for COVID-19 after he received a dose while hospitalized at Walter Reed
Medical Center earlier this month. Both Eli Lilly and Regeneron have
applied for emergency use authorizations of their antibody therapies.


.